Author

Miguel Cosenza‐Contreras

University of FreiburgORCID 0000-0002-9727-3229Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:proteomics· 4 Research Focus:differential expression· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 1

Frequent Co-Authors

Oliver SchillingiD· 4 shared Niko PinteriD· 3 shared Tilman WerneriD· 3 shared Tobias FeileniD· 3 shared Frank HauseiD· 2 shared Konrad KurowskiiD· 2 shared Adrianna Seredynska· 1 shared Agnes Schäfer· 1 shared

Activity by Year

2024-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

Oliver SchillingORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Proteomic characterization of sporadic clear cell renal cell carcinoma reveals a matrix-dense pseudocapsule and heterogeneous tumor subtypes

Tobias Feilen, Grigor Andreev, Manuel Rogg, Miguel Cosenza‐Contreras, Niko Pinter, Max Zirngibl, Antonia Elsässer, Pitter F. Huesgen, Markus Tobias Grabbert, Christoph Schell, Oliver Schilling

This study uses proteomics to characterize sporadic ccRCC, identifying a matrix-dense pseudocapsule and five tumor subtypes with distinct biological features.

bioRxiv · Oct 23, 2025 · PreprintMolecular Biology

Serum Proteome Profiling Identifies N-Cadherin and C-Met as Early Marker Candidates of Therapeutic Response to Neoadjuvant Chemotherapy in Breast Cancer

Ines Derya Steenbuck, Miguel Cosenza‐Contreras, Klemens Fröhlich, Bettina A. Mayer, Konrad Kurowski, Tilman Werner, Meike Reinold, Matthias Fahrner, Frank Hause, Adrianna Seredynska, Tobias Feilen, Andrea Ritter, Armelle Arnoux, Martin Lothar Biniossek, Daniela Weiß, , Oliver Schilling

bioRxiv · May 24, 2024 · PreprintCancer Biology

Proteomic profiling of IDH-wildtype Glioblastoma Tissue and Serum uncovers prognostic Subtypes and Marker Candidates

Tilman Werner, Agnes Schäfer, Michael Hennes, Miguel Cosenza‐Contreras, Guadalupe Espadas, Eduard Sabidó, Lena Cook, Axel Pagenstecher, Niko Pinter, Tobias Feilen, Alexander Grote, Christopher Nimsky, Jörg Walter Bartsch, Oliver Schilling

This study identifies proteomic subtypes and recurrence patterns in IDH-wildtype glioblastoma using tissue and serum samples, revealing prognostic markers and proteomic plasticity in recurrent tumors.

bioRxiv · Feb 29, 2024 · PreprintCancer Biology

Proteomic Characterization of Intrahepatic Cholangiocarcinoma Identifies Distinct Subgroups and Proteins Associated with Time-To-Recurrence

Tilman Werner, Klara-Luisa Budau, Miguel Cosenza‐Contreras, Frank Hause, Konrad Kurowski, Niko Pinter, Julia B. Schüler, Martin Werner, Carlie Sigel, Laura H. Tang, Peter Bronsert, Oliver Schilling

This study identifies two proteomic subgroups of intrahepatic cholangiocarcinoma with distinct time-to-recurrence rates and biological processes.

bioRxiv · Feb 28, 2024 · PreprintCancer Biology